scholarly journals More evidence is required for short-term treatment of exacerbations of chronic obstructive pulmonary disease: 3 days or no antibiotic at all?

2007 ◽  
Vol 13 (7) ◽  
pp. 748-749 ◽  
Author(s):  
C. Llor ◽  
M. Miravitlles
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Term Treatment ◽  
Chronic Obstructive ◽  
Short Term ◽  
Short Term Treatment ◽  
Obstructive Pulmonary Disease

scholarly journals Short-Term Versus Long-Term Systemic Corticosteroid Use in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients

2021 ◽  
Vol 28 (1) ◽  
pp. 59-65
Author(s):  
Samah Alshehri ◽  
Mai Alalawi ◽  
Abdulrahman Makeen ◽  
Ammar Jad ◽  
Ahmed Alhuwaysi ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Systemic Corticosteroid ◽  
Term Treatment ◽  
Chronic Obstructive ◽  
Copd Exacerbation ◽  
Short Term ◽  
Short Term Treatment ◽  
Obstructive Pulmonary Disease ◽  
Systemic Corticosteroids

Background: The administration of systemic corticosteroids in chronic obstructive pulmonary disease (COPD) exacerbation is the first line of management. The duration of this administration, however, is not well established in clinical practice. The objective of this study is to compare the clinical outcomes between short-term and long-term corticosteroid use in the acute exacerbation of COPD patients. Methods: A single-centre, retrospective cohort study was conducted. From 2014 to 2018, all patients over 40 years old with COPD who were admitted to the hospital with a case of COPD exacerbation and received systemic corticosteroids at presentation were included. The subjects were divided into two groups according to the duration of systemic corticosteroid therapy. The primary outcome was hospital re-admission within 180 days. The secondary outcomes were 30 days mortality and length of hospitalisation. The two groups were compared using an independent sample t-test, a Chi-square test, and a Mann-Whitney U test, according to the data type. Results: Eighty patients met the inclusion criteria. A total of 52 (65%) patients completed long-term therapy, while 28 (35%) patients were on short-term treatment. A total of 15 (28.8%) patients reached the primary endpoint in the long-term treatment group versus 19 (67.9%) in the short-term treatment group (P = 0.001). The 30-day mortality was 4 (7.7%) and 0 (0%), respectively, and the median length of hospitalisation was 6.5 and 7.5 days in the long-term group and short-term group, respectively (P = 0.32, P = 0.88). Conclusion: Long-term corticosteroid use in the management of acute COPD exacerbation was significantly associated with fewer 180 days re-admission. The duration of corticosteroid use remains controversial, and further studies are recommended to assess the relationship between patient profile and adherence to therapy post-discharge with re-exacerbation.

Factors influencing short-term re-admission and one-year mortality in patients with chronic obstructive pulmonary disease

Respirology ◽  
2007 ◽  
Vol 12 (4) ◽  
pp. 560-565 ◽  
Author(s):  
Shih-Feng LIU ◽  
Kuan-Chun LIN ◽  
Chien-Hung CHIN ◽  
Yung-Che CHEN ◽  
Hsueh-Wen CHANG ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Short Term ◽  
Obstructive Pulmonary Disease ◽  
Factors Influencing ◽  
One Year
Sign in / Sign up

Export Citation Format

Share Document